The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Mercury Laboratories Ltd

Mercury Laboratories Ltd

BSE 538964 · NSE MERCURYLAB · ISIN INE947G01011 · Group X · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹773.65

-0.94%

BSE close, 28 August 2026

Market cap

₹92.84 cr

0.1 cr shares · Micro cap

Free float

₹18.51 cr

as published

P/E · P/B

22.3× · 1.80×

EPS ₹34.70 · BV ₹429.81

FY25-26 rev / PAT

75.94 / 4.83

₹ cr, as filed

Filings, window

13

3 selected · 23%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹620.55 52-WK HIGH ₹942.90 ₹773.65 47% of range
Against 52-week high-17.9%
Against 52-week low+24.7%
Day change-0.94%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹34.70
Price / earnings22.30×
Price / book1.80×
Book value — derived, price ÷ P/B₹429.81
Return on equity8.05%
Operating margin7.79%
Net margin1.87%

Consistency check

P/B ÷ P/E, which must equal ROE
8.07%
ROE as published
8.05%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 15.96 0.30 2.48 7.79% 1.87%
Mar-26 · Q 20.44 1.23 10.21 13.27% 5.99%
FY25-26 75.94 4.83 40.28 13.96% 6.37%

Quarter on quarter

Revenue, quarter on quarter
-21.9%
Net profit, quarter on quarter
-75.6%
Operating margin, quarter on quarter
-548 bps

Disclosure profile 13 filings in the window

0 median 17.0 p75 · 25 sector max 52 13 34th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Change in Management2
Change in Directorate1
Selected sub-total3
Procedural
AGM / EGM3
Newspaper Publication3
Annual Report1
Compliance Certificate1
General1
Trading Window1
Procedural sub-total10
Total13

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

13 filings · 3 selected · busiest 2026-09-01 and 2026-09-30

Filing rhythm · the twelve most recent

2026-08-202026-10-06

SelectedProcedural

Filings

13 in the window · 5 earlier on record

  1. 6 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Reg 74(5) of SEBI (DP) regulations, 2018 for the quarter ended on September 30, 2026 is attached

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 30 September 2026 ·

    Change in Directorate

    Change in Directorate

    Intimation regarding cessation of director upon conclusion of AGM

    Company Update / Change in Directorate View filing →

  3. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Submission of voting results of the 45th AGM of the Company alongwith scrutinizers report thereon

    AGM/EGM / AGM View filing →

  4. 28 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceeding of the 45th AGM of the Company is attched

    AGM/EGM / AGM View filing →

  5. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of closure of trading window for the announcement of unaudited financial statment for the quarter and half year ended on September 30, 2026

    Insider Trading / SAST / Closure of Trading Window View filing →

  6. 3 September 2026 ·

    Change in Management

    Change in Management

    Intimation for appointment of Manager HR as senior Management is attched

    Company Update / Change in Management View filing →

  7. 2 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Submission of Newspaper publication of 45th AGM notice of the Company scheduled to be held on September 28, 2026

    Company Update / Newspaper Publication View filing →

  8. 1 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Please find enclosed herewith a copy of 45th Annual Report of the Company for the Financial Year ended March 31, 2026.

    Others / Reg. 34 (1) Annual Report View filing →

  9. 1 September 2026 ·

    AGM / EGM

    Submission Of Notice Of The 45Th Annual General Meeting Of The Company

    Please find enclosed herewith a copy of 45th AGM notice of the Company scheduled to be held on 28/09/2026 at 11.30 AM IST

    AGM/EGM / AGM View filing →

  10. 27 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper publication regarding 45th AGM to be held on September 28, 2026 is attached

    Company Update / Newspaper Publication View filing →

  11. 21 August 2026 ·

    Change in Management

    Change in Management

    Intimation regarding appointment of Mr. Sunil Sharma and resignation of Ms. Seema Salvi as HOD injectable

    Company Update / Change in Management View filing →

  12. 20 August 2026 ·

    General

    Communication To Shareholders - Intimation On Tax Deduction On Dividend

    Communication to Shareholders on TDS on the dividend for the FY 25-26 is attached

    Company Update / General View filing →

  13. 27 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper advertisement of unaudited financial result for the quarter ended on June 2026 is attched

    Company Update / Newspaper Publication View filing →

RSS feed for Mercury Laboratories Ltd · the 50 most recent filings